Blood samples were collected from the patient and patient’s parents after obtaining written informed consent for genetic testing of the coding regions of the following genes linked with corneal dystrophies: CHST6, TGFBI, KRT3, KRT12, COL8A2, SLC4A11, TACSTD2, UBIAD1, VSX1, and ZEB1. The next-generation sequencing (NGS) technique was performed with the SeqCap EZ Hyper Cap protocol and a NimbleGen SeqCap EZ probe kit (Roche Sequencing Solutions, Inc; CA; USA) using a NextSeq sequencer by Illumina (Illumina, San Diego, CA, USA). The gene discussed is TGFBI; the disease is corneal dystrophy.